YOUR US MARKET PARTNER
Bridging Biotech Innovation to US Commercial Success
Expert guidance on payer dynamics and commercialization for European biotech.
Payer Dynamics
We navigate the complex landscape of US healthcare reimbursement, ensuring your biotech innovations meet the rigorous standards of payers and insurance providers.
Specialized Market Entry
Commercialization
Our team develops comprehensive go-to-market strategies that bridge the gap between European biotech innovation and the US commercialization cycle.
Market Access
We provide insights into US market trends and regulatory pathways, helping small biotech companies secure the commercial success they deserve.
THE TEAM
Experience Across the Atlantic
At Bridge Pharma Consulting, our mission is to bridge the gap between world-class European science and commercial success in the US market. We believe that breakthrough therapies in diabetes and oncology deserve to reach the patients who need them — and that the difference between a great drug and a successful drug is often not the science, but the commercial strategy behind it. We bring 17 years of front-line US pharmaceutical expertise to European pharma and biotech companies, giving them the field-level knowledge, commercial skills, and strategic clarity to launch, grow, and lead with confidence.
US Market Intelligence
ABOUT
Patrice DavisÂ
FounderÂ
Three years ago, I transitioned from a successful seventeen-year career at a top-tier global pharmaceutical manufacturer to relocate to Paris. Arriving with a new language to learn and a network to build, I was fueled by the conviction that my specialized industry expertise held profound global relevance and that my most impactful work was just beginning.
Since then, my time in Europe has been transformative. I have observed that while European biotech organizations consistently pioneer groundbreaking science, the hurdle of U.S. commercial entry remains steep and complex. Successfully engaging with payer systems, managing GPO dynamics, and understanding the nuances of how U.S. oncologists and endocrinologists make prescribing choices requires a level of tactical foresight that raw data simply cannot provide. Drawing on nearly two decades of field experience, I have developed strategies to help clients bypass the common errors that derail overseas market expansion.
This mission is the heartbeat of Bridge Pharma Consulting. Our boutique consultancy operates on the fundamental belief that life-changing innovations in diabetes and oncology must effectively reach the patients who depend on them. Frequently, the barrier to success is not the clinical data, but the tactical execution of a high-level commercial plan. Based in Paris but serving a worldwide roster of clients, we offer an insider’s perspective on the American pharmaceutical market. If you are prepared to launch your innovations in the United States, I am here to guide your team through that journey with certainty.